1. 1) Chan ACL and Chan JKC : Haematolymphoid tumors. In Barnes L, Eveson JW, eds ; WHO classification of Tumours, Pathology and Genetics of Head and Neck Tumours. IARC Press, Lyon, 2005, p199-205.
2. 2) Stein H, Chan JKC, et al : Diffuse large B-cell lymphoma, not otherwise specified. In Swerdlow SH, Campo E, eds ; World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Fourth Edition, IARC Press, Lyon, 2008, p233-237.
3. 3) Gascoyne RD, Chan JKC, et al : Diffuse large B-cell lymphoma, not otherwise specified. In Swerdlow SH, Campo E, eds ; World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition, IARC Press, Lyon, 2017, p291-297.
4. 4) Chuang WY, Chang H, et al : CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. Virchows Arch 467: 571-582, 2015.
5. 5) Miyazaki K, Yamaguchi M, et al : CD5 positive diffuse large B cell lymphoma : a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol 22: 1601-1607, 2011.